Insights From Technical Analysis
.webp&w=828&q=75)
Sinclair Gold (ASX: SGC): Chart Signals Caution Despite Mt Henry Growth
Sinclair Gold is advancing its Mt Henry gold project in Western Australia through drilling, funding, and resource growth plans. The company aims to expand its 915,000-ounce resource while testing deeper mineralisation and preparing for a late-2026 resource update.
.webp&w=828&q=75)
Liontown (ASX: LTR) Lithium Roar Hits a Fault Line: Kathleen Valley Advances as LTR Breaks Support
Liontown is transitioning from development to production as Kathleen Valley ramps up. While operational progress continues, weakness in the lithium market and technical selling have weighed sentiment, making execution, costs, and expansion progress key factors for investors.
.webp&w=828&q=75)
Aeris Resources (ASX: AIS): Cash‑Rich, Copper‑Gold Growth with Strategic Expansion Momentum
Aeris Resources (ASX: AIS) delivers solid FY26 production, strong cash generation, and transformational growth via South Cobar acquisition, positioning for sustained copper‑gold expansion into FY27.
.webp&w=828&q=75)
Vulcan Energy Resources (ASX: VUL): Zero‑Carbon Ambition, Strategic Progress, and Repricing Potential
Vulcan Energy Resources (ASX: VUL) advances its Zero Carbon Lithium project with progressing development, strategic partnerships, and strengthened funding pathways, positioning the company as a unique European lithium supplier amid rising demand for decarbonised battery materials.
Invictus Energy (ASX: IVZ): Technical Support Meets Exploration Upside
Invictus Energy is progressing its Cabora Bassa gas project in Zimbabwe, with Mukuyu appraisal and Musuma-1 drilling as key catalysts. While the PPSA reduces regulatory risk, IVZ remains a volatile, pre-revenue explorer reliant on external funding.
Lumos Diagnostics (ASX: LDX): Enters Its Proof Phase as LDX Breaks the Downtrend
Lumos Diagnostics continues to expand its commercial footprint through FDA clearance, growing U.S. adoption, manufacturing partnerships, and paediatric research. The company now focuses on turning regulatory success and market access into recurring sales, broader reimbursement, and sustainable long-term growth.